Microbiome Connect’s Post

The countdown is on! A reminder that the final early bird prices for Microbiome Connect end tomorrow - October 18 ⏰ With Pfizer, Unilever, FDA, Concerto Biosciences and Vedanta Biosciences, Inc. confirmed, secure your spot to join them at the only global meeting for the microbiome therapeutic & scientific community to retrieve R&D and commercial market intelligence. Why wait to pay the full rate? Book before midnight tomorrow and save $400: https://lnkd.in/eCWtgESx

Meet Our Platinum Partner!👏 We are delighted to introduce CosmosID as our esteemed Platinum Partner, bringing award-winning, end-to-end microbiome solutions to Microbiome Connect in November. Meet the CosmosID team at the Aloft Boston Seaport District Hotel and discuss solutions for providing an affordable and seamless customer experience. Download the agenda for our 2024 event now: https://hubs.ly/Q02Sz9m_0 #microbiome #microbiomeconnect

Join us at Microbiome Connect 📍Aloft Boston Seaport District Hotel, November 20-21, 2024. This year, we’re hosting 250+ scientists and entrepreneurs from over 120 different biotech, pharma and academic institutions. With a host of limited space opportunities, now is the perfect time to curate your ideal event agenda. Download the agenda here to discover more about what you can expect if you join us there: https://hubs.ly/Q02Sz95b0 #microbiomeconnect #healthcareinnovation #microbiomeconference #microbiome

🚨 The obesity and metabolic health landscape is evolving fast! 🚨 As supply issues with Ozempic persist for Novo Nordisk and Eli Lilly and Company launch an unconventional but affordable single-dose version of Zepbound; there has never been a more crucial time to bring the obesity and metabolic health industry together. Join us at the Obesity & Metabolic Innovation Forum (Dec 4-5, Boston) to get the inside scoop on the latest in weight loss, GLP-1, and cardiometabolic solutions. What’s in it for you? - Strategic expertise from industry leaders like Novo Nordisk, Sanofi, BCBS, and Cigna Healthcare - Exclusive innovations in delivery methods, new indications, and beyond-the-pill strategies - Unmatched networking with top decision-makers and investors ➡️ Download the agenda now and secure your place alongside global thought leaders! https://hubs.ly/Q02NX0GW0 #ObesityInnovation #MetabolicHealth #GLP1 #HealthcareInnovation #NetworkingOpportunities

🚀 Exciting News for the Obesity & Metabolic Health Community! 🚀 Eli Lilly and Company's recent decision to discount Zepbound highlights a critical need for broader access to effective obesity treatments. As we navigate challenges like high costs, supply constraints, and off-label usage, it's clear that the industry is evolving—and fast. Join us at the Obesity & Metabolic Innovation Forum on December 4-5 in Boston to connect with the leaders shaping the future of weight management and metabolic therapies. From pharmaceutical giants like Eli Lilly and Company and Novo Nordisk to groundbreaking start-ups, this event is your opportunity to engage with the innovators driving change. Here’s what you can expect: 🔍 In-Depth Insights: Learn about patient access, affordability, and regulatory pathways for GLP-1 therapies and beyond. 💡 Market Strategies: Discover the latest trends in GLP-1 agonist market access, new investment opportunities, and the integration of digital tools in patient care. 🤝 Networking: Connect with key players—pharma and biotech leaders, investors, payers, and regulators—who are at the forefront of metabolic health innovation. Be the first to get access to the full event program and unlock Early-Bird Discounts, exclusive speaker announcements, and more! Register your interest today: https://hubs.ly/Q02N3-9b0 #ObesityInnovation #MetabolicHealth #GLP1 #HealthcareLeadership #PharmaInnovation 🔗Follow Obesity & Metabolic Innovation Forum to stay up-to-date with the latest in Obesity & Metabolic Health! ➡️ Don’t miss out on key trends, insights, and industry news

⏰ Early bird ends this Friday ⏰ Where will you be on November 20-21? Ferring Pharmaceuticals, Nestlé Health Science, and Daewoong Pharmaceutical will be at the Aloft Boston Seaport District Hotel alongside 200+ industry trailblazers at the 11th Annual Microbiome Connect. Whether your interests are business development, risk mitigation, R&D innovation, or manufacturing learnings - you need to be there. There's no time to lose! ⚠️ Save up to $1,200 before the early bird expires this Friday: https://lnkd.in/eCWtgESx

📣 PHAGE FUTURES RETURNS 📣 Your leading phage therapy networking platform addressing the critical challenges in regulation, production, investment, R&D, and commercial landscapes is returning November 19 2024: https://hubs.ly/Q02JnqQx0 The all-new agenda will focus on: 💡 𝐀𝐝𝐝𝐫𝐞𝐬𝐬𝐢𝐧𝐠 𝐭𝐡𝐞 𝐧𝐞𝐞𝐝 𝐟𝐨𝐫 𝐩𝐡𝐚𝐠𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐠𝐮𝐢𝐝𝐚𝐧𝐜𝐞 𝐰𝐢𝐭𝐡 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐢𝐨𝐧 𝐟𝐫𝐨𝐦 𝐌𝐇𝐑𝐀, 𝐅𝐃𝐀 𝐚𝐧𝐝 𝐇𝐞𝐚𝐥𝐭𝐡 𝐂𝐚𝐧𝐚𝐝𝐚 📈 𝐎𝐯𝐞𝐫𝐜𝐨𝐦𝐢𝐧𝐠 𝐡𝐮𝐫𝐝𝐥𝐞𝐬 𝐢𝐧 𝐩𝐡𝐚𝐠𝐞 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐚𝐧𝐝 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐮𝐬𝐞 𝐜𝐚𝐬𝐞𝐬 𝐨𝐟 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐞.𝐠. 𝐚𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐢𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 💰 𝐖𝐡𝐚𝐭 𝐭𝐡𝐞 𝐩𝐡𝐚𝐠𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐧𝐞𝐞𝐝𝐬 𝐭𝐨 ‘𝐛𝐨𝐨𝐦’ 𝐝𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧𝐬 𝐰𝐢𝐭𝐡 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬, 𝐟𝐮𝐧𝐝𝐞𝐫𝐬, 𝐚𝐧𝐝 𝐢𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬 💥 𝐌𝐚𝐣𝐨𝐫 𝐩𝐫𝐞𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥/𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐛𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐬 𝐚𝐜𝐫𝐨𝐬𝐬 𝐡𝐮𝐦𝐚𝐧 𝐡𝐞𝐚𝐥𝐭𝐡, 𝐚𝐧𝐢𝐦𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡, 𝐚𝐪𝐮𝐚𝐜𝐮𝐥𝐭𝐮𝐫𝐞, 𝐚𝐪𝐮𝐚𝐜𝐮𝐥𝐭𝐮𝐫𝐞, 𝐧𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧, 𝐚𝐧𝐝 𝐜𝐨𝐬𝐦𝐞𝐭𝐢𝐜 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐞𝐬 Download the full program to find out more: https://hubs.ly/Q02JnxXS0

Don’t just take our word for it… 👀 Take a look at what Exeliom Biosciences, Concerto Biosciences, The University of British Columbia and The Microbiome Mavericks had to say about Microbiome Connect 2023! #MicrobiomeConnect #MicrobiomeConference

✨ We're baaaack ✨ Your leading event for business conversations in microbiome drug development returns for its 11th iteration (November 20-21) featuring speakers from the likes of Pfizer, FDA and BIOMATZ. You can join us at the Aloft Boston Seaport District Hotel and leave armed with the tools you need to effectively: 💡 𝐀𝐝𝐝𝐫𝐞𝐬𝐬 𝐢𝐧𝐭𝐞𝐫-𝐢𝐧𝐝𝐢𝐯𝐢𝐝𝐮𝐚𝐥 𝐯𝐚𝐫𝐢𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐨𝐟 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐩𝐨𝐨𝐥𝐬 💰 𝐃𝐫𝐢𝐯𝐞 𝐩𝐮𝐛𝐥𝐢𝐜 𝐚𝐧𝐝 𝐩𝐫𝐢𝐯𝐚𝐭𝐞 𝐟𝐮𝐧𝐝𝐢𝐧𝐠 📈 𝐒𝐡𝐚𝐩𝐞 𝐲𝐨𝐮𝐫 𝐩𝐫𝐨𝐝𝐮𝐜𝐭 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐲 If being part of the Microbiome Therapeutics conversation is important to your research or business goals, this is the place to be. Download the agenda to find out more: https://lnkd.in/eAnmMimF

Are you joining us in Seoul? Don't miss out on your chance to connect with 200 industry leading experts across the microbiome industry. Book before MIDNIGHT on Friday and save up to $700 on your registration: https://hubs.ly/Q02s_SHz0 #MicrobiomeConnect #MicrobiomeConnectAsia #MicrobiomeConnectSeries